Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lidia A. Nekrasova
Observed names:
Lidia Nekrasova,
Nekrasova, Lidia A.
Institution:
Moscow City Oncology Hospital №62
Observed institutions:
Lomonosov Moscow State University,
Ministry of Health of the Russian Federation,
Medical Radiological Research Center,
P.A. Hertzen Moscow Oncology Research Institute,
Moscow City Oncology Hospital №62
ORCID:
0009-0001-2348-0831
Observed ORCID:
0009-0001-2348-0831
OpenAlex ID:
A5099848712
Prognostic Impact of Phenotypic and Genetic Features of Pancreatic Malignancies
2025
·
Mikhail B. Potievskiy
, Lidia A. Nekrasova
, et al.
·
Life
·
1
PDF
Dynamics of blood microsatellite instability (bMSI) burden predicts outcome of a patient treated with immune checkpoint inhibitors: a case report of hyperprogressive disease
2025
·
Daria Kravchuk
, Alexandra Lebedeva
, et al.
·
Frontiers in Immunology
·
1
PDF
Actinium-225-PSMA versus lutetium-177-PSMA radioligand therapy for metastatic castration-resistant prostate cancer: results of an observational study
2026
·
Tatiana Yu Kochetova
, Mikhail B. Potievskiy
, et al.
·
Frontiers in Oncology
PDF
Personal approach for cancer treatment: A meta-analysis of Phase II clinical trials
2025
·
Mikhail B. Potievskiy
, Elena P. Zharova
, et al.
·
PLoS ONE
PDF
The problem of pancreatic fistula development after pancreatic surgery in oncological patients
2024
·
Mikhail B. Potievskiy
, Leonid O. Petrov
, et al.
·
Russian Journal of Oncology
Critically and Moderately Ill COVID-19 Patients Have Different Risk Factors for Arterial Thromboembolism and Risk Score for Critically Ill Patients
2024
·
Daria Morozova
, Kirill Nezhdanov
, et al.
·
SSRN Electronic Journal
Show more works
View as search
Works count:
7
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type